메뉴 건너뛰기




Volumn 313, Issue , 2007, Pages 101-128

Treatment of acute promyelocytic leukemia by retinoids

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIFIBRINOLYTIC AGENT; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FIBRINOGEN; HEPARIN; HYDROXYUREA; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; RETINOIC ACID; RETINOID DERIVATIVE; STEROID; TAMIBAROTENE; TIOGUANINE; ANTINEOPLASTIC AGENT;

EID: 33846988679     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-34594-7_7     Document Type: Review
Times cited : (57)

References (132)
  • 4
    • 0025875679 scopus 로고
    • The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
    • de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684
    • (1991) Cell , vol.66 , pp. 675-684
    • de The, H.1    Lavau, C.2    Marchio, A.3    Chomienne, C.4    Degos, L.5    Dejean, A.6
  • 5
    • 0025780876 scopus 로고
    • Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
    • Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663-674
    • (1991) Cell , vol.66 , pp. 663-674
    • Kakizuka, A.1    Miller Jr, W.H.2    Umesono, K.3    Warrell Jr, R.P.4    Frankel, S.R.5    Murty, V.V.6    Dmitrovsky, E.7    Evans, R.M.8
  • 7
    • 0032934735 scopus 로고    scopus 로고
    • The thrombophilic state in acute promyelocytic leukemia
    • Tallman MS (1999) The thrombophilic state in acute promyelocytic leukemia. Semin Thromb Hemost 25:209-215
    • (1999) Semin Thromb Hemost , vol.25 , pp. 209-215
    • Tallman, M.S.1
  • 9
    • 0023119073 scopus 로고
    • Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?
    • Goldberg MA, Ginsburg D, Mayer RJ, Stone RM, Maguire M, Rosenthal DS, Antin JH (1987) Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 69:187-191
    • (1987) Blood , vol.69 , pp. 187-191
    • Goldberg, M.A.1    Ginsburg, D.2    Mayer, R.J.3    Stone, R.M.4    Maguire, M.5    Rosenthal, D.S.6    Antin, J.H.7
  • 10
    • 0023925511 scopus 로고
    • Beneficial effect of heparin in the management of patients with APL
    • Hoyle CF, Swirsky DM, Freedman L, Hayhoe FG (1988) Beneficial effect of heparin in the management of patients with APL. Br J Haematol 68:283-289
    • (1988) Br J Haematol , vol.68 , pp. 283-289
    • Hoyle, C.F.1    Swirsky, D.M.2    Freedman, L.3    Hayhoe, F.G.4
  • 12
    • 0024519006 scopus 로고
    • Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital
    • Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD (1989) Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 73:1116-1122
    • (1989) Blood , vol.73 , pp. 1116-1122
    • Cunningham, I.1    Gee, T.S.2    Reich, L.M.3    Kempin, S.J.4    Naval, A.N.5    Clarkson, B.D.6
  • 14
    • 0025865947 scopus 로고
    • Treatment of acute promyelocytic leukemia with alltrans retinoic acid
    • Fenaux P, Degos L (1991) Treatment of acute promyelocytic leukemia with alltrans retinoic acid. Leuk Res 15:655-657
    • (1991) Leuk Res , vol.15 , pp. 655-657
    • Fenaux, P.1    Degos, L.2
  • 17
    • 0036838645 scopus 로고    scopus 로고
    • Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: Final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
    • Avvisatti G, Petti MC, Lo-Coco F, et al (2002) Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood 100:3141-3146
    • (2002) Blood , vol.100 , pp. 3141-3146
    • Avvisatti, G.1    Petti, M.C.2    Lo-Coco, F.3
  • 21
    • 34548653068 scopus 로고    scopus 로고
    • Reference deleted in proof
    • Reference deleted in proof
  • 24
    • 0025836467 scopus 로고
    • Treatment of acute promyelocytic leukemia: A report of 70 cases
    • Fenaux P, Pollet J, Vandebossche L, et al (1991) Treatment of acute promyelocytic leukemia: a report of 70 cases. Leuk Lymphoma 4:249-256
    • (1991) Leuk Lymphoma , vol.4 , pp. 249-256
    • Fenaux, P.1    Pollet, J.2    Vandebossche, L.3
  • 26
    • 0025201879 scopus 로고
    • All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
    • Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704-1709
    • (1990) Blood , vol.76 , pp. 1704-1709
    • Castaigne, S.1    Chomienne, C.2    Daniel, M.T.3    Ballerini, P.4    Berger, R.5    Fenaux, P.6    Degos, L.7
  • 27
  • 28
    • 0026040363 scopus 로고
    • A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients
    • Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ (1991) A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78:1413-1419
    • (1991) Blood , vol.78 , pp. 1413-1419
    • Chen, Z.X.1    Xue, Y.Q.2    Zhang, R.3    Tao, R.F.4    Xia, X.M.5    Li, C.6    Wang, W.7    Zu, W.Y.8    Yao, X.Z.9    Ling, B.J.10
  • 30
    • 0025241453 scopus 로고
    • All-trans retinoic acid in acutepromyelocytic leukemias. II. Invitrostudies: Structure-function relationship
    • Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L (1990) All-trans retinoic acid in acutepromyelocytic leukemias. II. Invitrostudies: structure-function relationship. Blood 76:1710-1717
    • (1990) Blood , vol.76 , pp. 1710-1717
    • Chomienne, C.1    Ballerini, P.2    Balitrand, N.3    Daniel, M.T.4    Fenaux, P.5    Castaigne, S.6    Degos, L.7
  • 31
    • 0026665926 scopus 로고
    • Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis
    • Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P (1992) Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 79:1916-1919
    • (1992) Blood , vol.79 , pp. 1916-1919
    • Elliott, S.1    Taylor, K.2    White, S.3    Rodwell, R.4    Marlton, P.5    Meagher, D.6    Wiley, J.7    Taylor, D.8    Wright, S.9    Timms, P.10
  • 32
    • 0026787010 scopus 로고
    • Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: Molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone
    • Ohashi H, Ichikawa A, Takagi N, Hotta T, Naoe T, Ohno R, Saito H (1992) Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone. Leukemia 6:859-862
    • (1992) Leukemia , vol.6 , pp. 859-862
    • Ohashi, H.1    Ichikawa, A.2    Takagi, N.3    Hotta, T.4    Naoe, T.5    Ohno, R.6    Saito, H.7
  • 33
    • 0026788363 scopus 로고
    • All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases
    • Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al (1992) All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood 80:2176-2181
    • (1992) Blood , vol.80 , pp. 2176-2181
    • Fenaux, P.1    Castaigne, S.2    Dombret, H.3    Archimbaud, E.4    Duarte, M.5    Morel, P.6    Lamy, T.7    Tilly, H.8    Guerci, A.9    Maloisel, F.10
  • 35
    • 0029911825 scopus 로고    scopus 로고
    • Treatment of acute promyelocytic leukaemia
    • Fenaux P, Degos L (1996) Treatment of acute promyelocytic leukaemia. Baillieres Clin Haematol 9:107-128
    • (1996) Baillieres Clin Haematol , vol.9 , pp. 107-128
    • Fenaux, P.1    Degos, L.2
  • 36
    • 0028228247 scopus 로고
    • Prolonged follow-up confirms that alltrans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group
    • Fenaux P, Wattel E, Archimbaud E, Sanz M, Hecquet B, Fegueux N, Guerci A, Link H, Fey M, Castaigne S, et al (1994) Prolonged follow-up confirms that alltrans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group. Blood 84:666-667
    • (1994) Blood , vol.84 , pp. 666-667
    • Fenaux, P.1    Wattel, E.2    Archimbaud, E.3    Sanz, M.4    Hecquet, B.5    Fegueux, N.6    Guerci, A.7    Link, H.8    Fey, M.9    Castaigne, S.10
  • 37
    • 0027368561 scopus 로고
    • Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
    • Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, et al (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood 82:3241-3249
    • (1993) Blood , vol.82 , pp. 3241-3249
    • Fenaux, P.1    Le Deley, M.C.2    Castaigne, S.3    Archimbaud, E.4    Chomienne, C.5    Link, H.6    Guerci, A.7    Duarte, M.8    Daniel, M.T.9    Bowen, D.10
  • 40
    • 0033566639 scopus 로고    scopus 로고
    • Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94:1192-1200
    • Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94:1192-1200
  • 43
    • 0033564337 scopus 로고    scopus 로고
    • Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the Randomized MRC Trial
    • Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH (1999) Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood 93:4131-4143
    • (1999) Blood , vol.93 , pp. 4131-4143
    • Burnett, A.K.1    Grimwade, D.2    Solomon, E.3    Wheatley, K.4    Goldstone, A.H.5
  • 47
    • 0034663162 scopus 로고    scopus 로고
    • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups
    • Sanz MA, Lo-Coco F (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247-1253
    • (2000) Blood , vol.96 , pp. 1247-1253
    • Sanz, M.A.1    Lo-Coco, F.2
  • 48
    • 0031017173 scopus 로고    scopus 로고
    • Treatment of newly diagnosed acute promyelocytic leukemiawithout cytarabine
    • Estey E, Thall PF, Pierce S, Kantarjian H, Keating M (1997) Treatment of newly diagnosed acute promyelocytic leukemiawithout cytarabine. J Clin Oncol 15:483-490
    • (1997) J Clin Oncol , vol.15 , pp. 483-490
    • Estey, E.1    Thall, P.F.2    Pierce, S.3    Kantarjian, H.4    Keating, M.5
  • 49
    • 0026684811 scopus 로고
    • Induction of retinoic acid-binding protein in normal and malignant humanmyeloid cells by retinoic acid in acute promyelocytic leukemia patients
    • Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C (1992) Induction of retinoic acid-binding protein in normal and malignant humanmyeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res 52:3329-3334
    • (1992) Cancer Res , vol.52 , pp. 3329-3334
    • Cornic, M.1    Delva, L.2    Guidez, F.3    Balitrand, N.4    Degos, L.5    Chomienne, C.6
  • 50
    • 0026536835 scopus 로고
    • Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia
    • Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299-303
    • (1992) Blood , vol.79 , pp. 299-303
    • Muindi, J.1    Frankel, S.R.2    Miller Jr, W.H.3    Jakubowski, A.4    Scheinberg, D.A.5    Young, C.W.6    Dmitrovsky, E.7    Warrell Jr, R.P.8
  • 52
    • 10744220024 scopus 로고    scopus 로고
    • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study par the PETHEMA group
    • Sanz A, Martin G, Gonzalez M, et al (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study par the PETHEMA group. Blood 103:1237-1243
    • (2004) Blood , vol.103 , pp. 1237-1243
    • Sanz, A.1    Martin, G.2    Gonzalez, M.3
  • 58
    • 0035525766 scopus 로고    scopus 로고
    • In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: A novel indicator of poor patient outcome
    • Cassinat B, Chevret S, Zassadowski F, Balitrand N, Guillemot I, Menot ML, Degos L, et al (2001) In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 98:2862-2864
    • (2001) Blood , vol.98 , pp. 2862-2864
    • Cassinat, B.1    Chevret, S.2    Zassadowski, F.3    Balitrand, N.4    Guillemot, I.5    Menot, M.L.6    Degos, L.7
  • 59
    • 0035525767 scopus 로고    scopus 로고
    • Prognostic significance of minimal residual disease detection and PML/RAR- isoformtype: Long-term follow-up in acute promyelocytic leukemia
    • Jurcic JG, Nimer SD, Scheinberg DA, DeBlasio T, Warrell RP Jr, Miller WH Jr (2001) Prognostic significance of minimal residual disease detection and PML/RAR- isoformtype: long-term follow-up in acute promyelocytic leukemia. Blood 98:2651-2656
    • (2001) Blood , vol.98 , pp. 2651-2656
    • Jurcic, J.G.1    Nimer, S.D.2    Scheinberg, D.A.3    DeBlasio, T.4    Warrell Jr, R.P.5    Miller Jr, W.H.6
  • 60
    • 0032147033 scopus 로고    scopus 로고
    • Early detection of relapse by prospective reverse transcriptase- polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial
    • Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F, Saglio G, Martinelli G, Petti MC, Santoro A, Pelicci PG, Mandelli F, Biondi A, Lo Coco F (1998) Early detection of relapse by prospective reverse transcriptase- polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial. Blood 92:784-789
    • (1998) Blood , vol.92 , pp. 784-789
    • Diverio, D.1    Rossi, V.2    Avvisati, G.3    De Santis, S.4    Pistilli, A.5    Pane, F.6    Saglio, G.7    Martinelli, G.8    Petti, M.C.9    Santoro, A.10    Pelicci, P.G.11    Mandelli, F.12    Biondi, A.13    Lo Coco, F.14
  • 62
    • 0035158509 scopus 로고    scopus 로고
    • Pulsed ATRA as single therapy restores long-term remission PML-RARalpha-positive acute promyelocytic leukemia patient real time quantification of minimal residual disease. A pilot study
    • Visani G, Buonamici S, Malagola M, Isidori A, Piccaluga PP, Martin G, Ottaviani E, Grafone T, Baccarani M, Tura S (2000) Pulsed ATRA as single therapy restores long-term remission PML-RARalpha-positive acute promyelocytic leukemia patient real time quantification of minimal residual disease. A pilot study. Leukemia 15:1696-1700
    • (2000) Leukemia , vol.15 , pp. 1696-1700
    • Visani, G.1    Buonamici, S.2    Malagola, M.3    Isidori, A.4    Piccaluga, P.P.5    Martin, G.6    Ottaviani, E.7    Grafone, T.8    Baccarani, M.9    Tura, S.10
  • 63
    • 0038446666 scopus 로고    scopus 로고
    • Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: Assessment of prognostic significance in adult patients from intergroup protocol 0129
    • Gallagher RE, Yeap BY, Bi W, et al (2003) Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood 101:2521-2528
    • (2003) Blood , vol.101 , pp. 2521-2528
    • Gallagher, R.E.1    Yeap, B.Y.2    Bi, W.3
  • 65
    • 0032946404 scopus 로고    scopus 로고
    • Extramedullary disease in acute promyelocytic leukemia
    • Evans GD, Grimwade DJ (1999) Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma 33:219-229
    • (1999) Leuk Lymphoma , vol.33 , pp. 219-229
    • Evans, G.D.1    Grimwade, D.J.2
  • 66
    • 33644976445 scopus 로고    scopus 로고
    • Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    • de Botton S, Sanz M, Chevret S, et al (2006) Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 20:35-41
    • (2006) Leukemia , vol.20 , pp. 35-41
    • de Botton, S.1    Sanz, M.2    Chevret, S.3
  • 67
    • 34548621538 scopus 로고    scopus 로고
    • Lo-Coco F, Vignetti M, Avvisatti G, et al (2004) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation: results of the AIDA-2000 trial of the Italian GIMEMA group. Blood 104 Suppl 1 Abstr 392
    • Lo-Coco F, Vignetti M, Avvisatti G, et al (2004) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation: results of the AIDA-2000 trial of the Italian GIMEMA group. Blood 104 Suppl 1 Abstr 392
  • 68
    • 0033858433 scopus 로고    scopus 로고
    • Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: Effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group
    • Lengfelder E, Reichert A, Schoch C, et al (2000) Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group. Leukemia 14:1362-1370
    • (2000) Leukemia , vol.14 , pp. 1362-1370
    • Lengfelder, E.1    Reichert, A.2    Schoch, C.3
  • 69
    • 0028557482 scopus 로고
    • Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience
    • Warrell RP Jr, Maslak P, Eardley A, Heller G, Miller WH Jr, Frankel SR (1994) Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia 8:929-933
    • (1994) Leukemia , vol.8 , pp. 929-933
    • Warrell Jr, R.P.1    Maslak, P.2    Eardley, A.3    Heller, G.4    Miller Jr, W.H.5    Frankel, S.R.6
  • 70
    • 0027517243 scopus 로고
    • Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells
    • Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, et al (1993) Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175-2181
    • (1993) Blood , vol.82 , pp. 2175-2181
    • Delva, L.1    Cornic, M.2    Balitrand, N.3    Guidez, F.4    Miclea, J.M.5    Delmer, A.6    Teillet, F.7    Fenaux, P.8    Castaigne, S.9    Degos, L.10
  • 71
    • 0034046084 scopus 로고    scopus 로고
    • Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P (2000) Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia. Leukemia 14:1006-1013
    • Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P (2000) Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia. Leukemia 14:1006-1013
  • 72
    • 16644373167 scopus 로고    scopus 로고
    • Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European acute promyelocytic leukemia group
    • de Botton S, Fawaz A, Chevret S, et al (2005) Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. J Clin Oncol 23:120-126
    • (2005) J Clin Oncol , vol.23 , pp. 120-126
    • de Botton, S.1    Fawaz, A.2    Chevret, S.3
  • 73
    • 0032529284 scopus 로고    scopus 로고
    • Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy
    • Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE (1998) Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 92:1172-1183
    • (1998) Blood , vol.92 , pp. 1172-1183
    • Ding, W.1    Li, Y.P.2    Nobile, L.M.3    Grills, G.4    Carrera, I.5    Paietta, E.6    Tallman, M.S.7    Wiernik, P.H.8    Gallagher, R.E.9
  • 74
    • 0035169587 scopus 로고    scopus 로고
    • Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid
    • Douer D, Estey E, Santillana S, Bennett JM, Lopez-Bernstein G, et al (2001) Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 97:73-80
    • (2001) Blood , vol.97 , pp. 73-80
    • Douer, D.1    Estey, E.2    Santillana, S.3    Bennett, J.M.4    Lopez-Bernstein, G.5
  • 75
    • 0028109056 scopus 로고
    • Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid
    • Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G (1994) Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leuk Res 18:587-596
    • (1994) Leuk Res , vol.18 , pp. 587-596
    • Mehta, K.1    Sadeghi, T.2    McQueen, T.3    Lopez-Berestein, G.4
  • 79
    • 3643104150 scopus 로고    scopus 로고
    • Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
    • Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90:1621-1625
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1621-1625
    • Warrell Jr, R.P.1    He, L.Z.2    Richon, V.3    Calleja, E.4    Pandolfi, P.P.5
  • 81
    • 0033982749 scopus 로고    scopus 로고
    • Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia
    • Jurcic JG, DeBlasio T, Dumont L, Yao TJ, Scheinberg DA (2000) Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia. Clin Cancer Res 6:372-380
    • (2000) Clin Cancer Res , vol.6 , pp. 372-380
    • Jurcic, J.G.1    DeBlasio, T.2    Dumont, L.3    Yao, T.J.4    Scheinberg, D.A.5
  • 83
    • 4243299380 scopus 로고
    • Study on anti-leukemic effect of tanshinone IIA in vitro and in vivo to acute promyelocytic leukemia
    • Yang Y, Liu T, Liang Y, Qin P, Yuan S (1994) Study on anti-leukemic effect of tanshinone IIA in vitro and in vivo to acute promyelocytic leukemia. Blood 94 Suppl 1
    • (1994) Blood , vol.94 , Issue.SUPPL. 1
    • Yang, Y.1    Liu, T.2    Liang, Y.3    Qin, P.4    Yuan, S.5
  • 91
    • 0035095714 scopus 로고    scopus 로고
    • Arsenic trioxide-and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study
    • Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R (2001) Arsenic trioxide-and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study. Am J Hematol 66:274-279
    • (2001) Am J Hematol , vol.66 , pp. 274-279
    • Kwong, Y.L.1    Au, W.Y.2    Chim, C.S.3    Pang, A.4    Suen, C.5    Liang, R.6
  • 93
    • 0034554742 scopus 로고    scopus 로고
    • Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction
    • Roberts TF, Sprague K, Schenkein D, Miller KB, Relias V (2000) Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction. Blood 96:4000-4001
    • (2000) Blood , vol.96 , pp. 4000-4001
    • Roberts, T.F.1    Sprague, K.2    Schenkein, D.3    Miller, K.B.4    Relias, V.5
  • 95
    • 0034050085 scopus 로고    scopus 로고
    • Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia
    • Che-Pin L, Huang MJ, Chang IY, Lin WY, Sheu YT (2000) Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia. Leuk Lymphoma 38:195-198
    • (2000) Leuk Lymphoma , vol.38 , pp. 195-198
    • Che-Pin, L.1    Huang, M.J.2    Chang, I.Y.3    Lin, W.Y.4    Sheu, Y.T.5
  • 97
    • 0036565879 scopus 로고    scopus 로고
    • Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: Potentiation by thiamine deficiency
    • Yip SF, Yeung YM, Tsui EY (2002) Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: potentiation by thiamine deficiency. Blood 99:3481-3482
    • (2002) Blood , vol.99 , pp. 3481-3482
    • Yip, S.F.1    Yeung, Y.M.2    Tsui, E.Y.3
  • 98
    • 0036566529 scopus 로고    scopus 로고
    • Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: A pilot report
    • Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR, Chen SS (2002) Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 99:3136-3143
    • (2002) Blood , vol.99 , pp. 3136-3143
    • Lu, D.P.1    Qiu, J.Y.2    Jiang, B.3    Wang, Q.4    Liu, K.Y.5    Liu, Y.R.6    Chen, S.S.7
  • 99
    • 0035161286 scopus 로고    scopus 로고
    • Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
    • Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH, Waxman S (2001) Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97:264-269
    • (2001) Blood , vol.97 , pp. 264-269
    • Jing, Y.1    Wang, L.2    Xia, L.3    Chen, G.Q.4    Chen, Z.5    Miller, W.H.6    Waxman, S.7
  • 100
    • 0036223312 scopus 로고    scopus 로고
    • Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide
    • Au WY, Chim CS, Lie AK, Liang R, Kwong YL (2002) Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide. Br J Haematol 117:130-132
    • (2002) Br J Haematol , vol.117 , pp. 130-132
    • Au, W.Y.1    Chim, C.S.2    Lie, A.K.3    Liang, R.4    Kwong, Y.L.5
  • 101
    • 0032753459 scopus 로고    scopus 로고
    • Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia
    • Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G (1999) Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Haematologica 84:963-968
    • (1999) Haematologica , vol.84 , pp. 963-968
    • Marasca, R.1    Zucchini, P.2    Galimberti, S.3    Leonardi, G.4    Vaccari, P.5    Donelli, A.6    Luppi, M.7    Petrini, M.8    Torelli, G.9
  • 103
    • 0033568238 scopus 로고    scopus 로고
    • Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
    • Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S (1999) Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94:2102-2111
    • (1999) Blood , vol.94 , pp. 2102-2111
    • Jing, Y.1    Dai, J.2    Chalmers-Redman, R.M.3    Tatton, W.G.4    Waxman, S.5
  • 105
    • 0034786069 scopus 로고    scopus 로고
    • Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia
    • Hong SH, Yang Z, Privalsky ML (2001) Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia. Mol Cell Biol 21:7172-7182
    • (2001) Mol Cell Biol , vol.21 , pp. 7172-7182
    • Hong, S.H.1    Yang, Z.2    Privalsky, M.L.3
  • 106
    • 0034663032 scopus 로고    scopus 로고
    • Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
    • Roboz GJ, Dias S, Lam G, Lane WJ, Soignet SL, Warrell RP Jr, Rafii S (2000) Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 96:1525-1530
    • (2000) Blood , vol.96 , pp. 1525-1530
    • Roboz, G.J.1    Dias, S.2    Lam, G.3    Lane, W.J.4    Soignet, S.L.5    Warrell Jr, R.P.6    Rafii, S.7
  • 110
    • 0027937940 scopus 로고
    • Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid
    • Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843-3849
    • (1994) Blood , vol.84 , pp. 3843-3849
    • Vahdat, L.1    Maslak, P.2    Miller Jr, W.H.3    Eardley, A.4    Heller, G.5    Scheinberg, D.A.6    Warrell Jr, R.P.7
  • 111
    • 0032870982 scopus 로고    scopus 로고
    • Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor
    • Ko BS, Tang JL, Chen YC, Yao M, Wang CH, Shen MC, Tien HF (1999) Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor. Leukemia 13:1406-1408
    • (1999) Leukemia , vol.13 , pp. 1406-1408
    • Ko, B.S.1    Tang, J.L.2    Chen, Y.C.3    Yao, M.4    Wang, C.H.5    Shen, M.C.6    Tien, H.F.7
  • 113
    • 0028339174 scopus 로고    scopus 로고
    • Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, et al (1994) Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264-3270
    • Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, et al (1994) Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264-3270
  • 114
    • 0030847751 scopus 로고    scopus 로고
    • Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2
    • Larson RS, Brown DC, Sklar LA (1997) Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood 90:2747-2756
    • (1997) Blood , vol.90 , pp. 2747-2756
    • Larson, R.S.1    Brown, D.C.2    Sklar, L.A.3
  • 115
    • 0028027147 scopus 로고
    • Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia
    • Visani G, Tosi P, Cenacchi A, Manfroi S, Gamberi B, Ottaviani E, Tura S (1994) Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia. Leuk Lymphoma 15:143-147
    • (1994) Leuk Lymphoma , vol.15 , pp. 143-147
    • Visani, G.1    Tosi, P.2    Cenacchi, A.3    Manfroi, S.4    Gamberi, B.5    Ottaviani, E.6    Tura, S.7
  • 116
    • 79960971354 scopus 로고    scopus 로고
    • Early onset chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL). Results of a randomized study
    • De Botton S, Coitteux V, Chevret S, Dombret H, Sanz M, San Miguel J, Caillot D, et al (2001) Early onset chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL). Results of a randomized study. Blood 98:766a
    • (2001) Blood , vol.98
    • De Botton, S.1    Coitteux, V.2    Chevret, S.3    Dombret, H.4    Sanz, M.5    San Miguel, J.6    Caillot, D.7
  • 118
    • 0028294564 scopus 로고
    • Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors
    • Tapiovaara H, Matikainen S, Hurme M, Vaheri A (1994) Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors. Blood 83:1883-1891
    • (1994) Blood , vol.83 , pp. 1883-1891
    • Tapiovaara, H.1    Matikainen, S.2    Hurme, M.3    Vaheri, A.4
  • 120
    • 0028337530 scopus 로고
    • Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage
    • Hashimoto S, Koike T, Tatewaki W, Seki Y, Sato N, Azegami T, Tsukada N, Takahashi H, Kimura H, Ueno M, et al (1994) Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 8:1113-1115
    • (1994) Leukemia , vol.8 , pp. 1113-1115
    • Hashimoto, S.1    Koike, T.2    Tatewaki, W.3    Seki, Y.4    Sato, N.5    Azegami, T.6    Tsukada, N.7    Takahashi, H.8    Kimura, H.9    Ueno, M.10
  • 121
    • 0033038544 scopus 로고    scopus 로고
    • Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: A role for adhesion molecules overexpression?
    • Torromeo C, Latagliata R, Avvisati G, Petti MC, Mandelli F (1999) Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: a role for adhesion molecules overexpression? Leukemia 13:312-313
    • (1999) Leukemia , vol.13 , pp. 312-313
    • Torromeo, C.1    Latagliata, R.2    Avvisati, G.3    Petti, M.C.4    Mandelli, F.5
  • 123
    • 0027267422 scopus 로고
    • Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia
    • Hakimian D, Tallman MS, Zugerman C, Caro WA (1993) Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia 7:758-759
    • (1993) Leukemia , vol.7 , pp. 758-759
    • Hakimian, D.1    Tallman, M.S.2    Zugerman, C.3    Caro, W.A.4
  • 125
    • 0028261220 scopus 로고
    • Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: Molecular analysis of the cell origin of the basophils
    • Iwakiri R, Inokuchi K, Dan K, Nomura T (1994) Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: molecular analysis of the cell origin of the basophils. Br J Haematol 86:870-872
    • (1994) Br J Haematol , vol.86 , pp. 870-872
    • Iwakiri, R.1    Inokuchi, K.2    Dan, K.3    Nomura, T.4
  • 128
    • 0032449676 scopus 로고    scopus 로고
    • Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia
    • Arun B, Berberian B, Azumi N, Frankel SR, Luksenburg H, Freter C (1998) Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia. Leuk Lymphoma 31:613-615
    • (1998) Leuk Lymphoma , vol.31 , pp. 613-615
    • Arun, B.1    Berberian, B.2    Azumi, N.3    Frankel, S.R.4    Luksenburg, H.5    Freter, C.6
  • 129
    • 0031907633 scopus 로고    scopus 로고
    • Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report
    • Levy V, Jaffarbey J, Aouad K, Zittoun R (1998) Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report. Ann Hematol 76:91-92
    • (1998) Ann Hematol , vol.76 , pp. 91-92
    • Levy, V.1    Jaffarbey, J.2    Aouad, K.3    Zittoun, R.4
  • 132
    • 0031868815 scopus 로고    scopus 로고
    • All trans retinoic acid as the possible cause of necrotizing vasculitis
    • Paydas S, Sahin B, Zorludemir S, Hazar B (1998) All trans retinoic acid as the possible cause of necrotizing vasculitis. Leuk Res 22:655-657
    • (1998) Leuk Res , vol.22 , pp. 655-657
    • Paydas, S.1    Sahin, B.2    Zorludemir, S.3    Hazar, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.